Framingham Risk Score for Prediction of Cardiovascular Diseases: A Population-Based Study from Southern Europe

Background The question about what risk function should be used in primary prevention remains unanswered. The Framingham Study proposed a new algorithm based on three key ideas: use of the four risk factors with the most weight (cholesterol, blood pressure, diabetes and smoking), prediction of overall cardiovascular diseases and incorporating the concept of vascular age. The objective of this study was to apply this new function in a cohort of the general non Anglo-Saxon population, with a 10-year follow-up to determine its validity. Methods The cohort was studied in 1992-94 and again in 2004-06. The sample comprised 959 randomly-selected persons, aged 30-74 years, who were representative of the population of Albacete, Spain. At the first examination cycle, needed data for the new function were collected and at the second examination, data on all events were recorded during the follow-up period. Discrimination was studied with ROC curves. Comparisons of prediction models and reality in tertiles (Hosmer-Lemeshow) were performed, and the individual survival functions were calculated. Results The mean risks for women and men, respectively, were 11.3% and 19.7% and the areas under the ROC curve were 0.789 (95%CI, 0.716-0.863) and 0.780 (95%CI, 0.713-0.847) (P<0.001, both). Cardiovascular disease events occurred in the top risk tertiles. Of note were the negative predictive values in both sexes, and a good specificity in women (85.6%) and sensitivity in men (79.1%) when their risk for cardiovascular disease was high. This model overestimates the risk in older women and in middle-aged men. The cumulative probability of individual survival by tertiles was significant in both sexes (P<0.001). Conclusions The results support the proposal for “reclassification” of Framingham. This study, with a few exceptions, passed the test of discrimination and calibration in a random sample of the general population from southern Europe.

[1]  P E Puddu,et al.  Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. , 2000, European heart journal.

[2]  Michael J. Pencina,et al.  Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study , 2009, Circulation.

[3]  Anne B. Newman,et al.  Framingham Risk Score and Alternatives for Prediction of Coronary Heart Disease in Older Adults , 2012, PloS one.

[4]  Philippe Van De Borne,et al.  Guidelines for the management of arterial hypertension , 2014 .

[5]  M. Woodward,et al.  Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC) , 2005, Heart.

[6]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[7]  Stephen S. Lim,et al.  Cardiovascular risk factors: when should we treat? , 2003, The Medical journal of Australia.

[8]  Tom Fahey,et al.  Predictive accuracy of the Framingham coronary risk score in British men:prospective cohort study , 2003, BMJ : British Medical Journal.

[9]  K. Anderson,et al.  An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.

[10]  Michael Böhm,et al.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Journal of hypertension.

[11]  Lluís Serra Majem,et al.  Tablas de evaluación del riesgo coronario adaptadas a la población española. Estudio DORICA , 2004 .

[12]  Steven Shea,et al.  Prevalence and Progression of Subclinical Atherosclerosis in Younger Adults With Low Short-Term but High Lifetime Estimated Risk For Cardiovascular Disease: The Coronary Artery Risk Development in Young Adults Study and Multi-Ethnic Study of Atherosclerosis , 2009, Circulation.

[13]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[14]  A. Albers,et al.  Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol. , 1985, Clinical chemistry.

[15]  V. Fuster,et al.  [Applied cardiological research. Challenges for the new millenium]. , 2002, Revista espanola de cardiologia.

[16]  M. Essink‐bot,et al.  Evidence-based guidelines, time-based health outcomes, and the Matthew effect. , 2007, European journal of public health.

[17]  H. Tunstall-Pedoe,et al.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.

[18]  J Marrugat,et al.  An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas , 2003, Journal of epidemiology and community health.

[19]  Valentin Fuster,et al.  Investigación cardiológica aplicada. Retos en el nuevo milenio , 2002 .

[20]  C. Sánchis,et al.  Prevalence, awareness, treatment, and control of hypertension in a Spanish population , 2004, European Journal of Epidemiology.

[21]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[22]  D Kromhout,et al.  Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart , 2000, Heart.

[23]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[24]  C. Sánchis,et al.  Using ankle-brachial index to detect peripheral arterial disease: prevalence and associated risk factors in a random population sample. , 2007, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[25]  Lisa Hartling,et al.  Meta-Analysis: Secondary Prevention Programs for Patients with Coronary Artery Disease , 2005, Annals of Internal Medicine.

[26]  Roberto Elosua,et al.  Factores de riesgo cardiovascular. Perspectivas derivadas del Framingham Heart Study , 2008 .

[27]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[28]  D. Lloyd‐Jones,et al.  Systematic Examination of the Updated Framingham Heart Study General Cardiovascular Risk Profile , 2009, Circulation.

[29]  Gary S Collins,et al.  An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study , 2009, BMJ : British Medical Journal.

[30]  G. Assmann,et al.  Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.

[31]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[32]  C. O’Donnell,et al.  [Cardiovascular risk factors. Insights from Framingham Heart Study]. , 2008, Revista espanola de cardiologia.

[33]  Ralph B D'Agostino,et al.  EVIDENCE BASED PUBLIC HEALTH POLICY AND PRACTICE Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA study , 2006 .

[34]  F. Rodríguez‐Artalejo,et al.  Mortality attributable to cardiovascular risk factors in Spain , 2003, European Journal of Clinical Nutrition.

[35]  Sara Rosenbaum,et al.  Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options. , 2005, The American journal of cardiology.

[36]  S. Monereo,et al.  [Tables of coronary risk evaluation adapted to the Spanish population: the DORICA study]. , 2004, Medicina clinica.

[37]  J. Hippisley-Cox,et al.  Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study , 2007, BMJ : British Medical Journal.

[38]  J. A. Divisón,et al.  Prevalencia de obesidad y su relación con el riesgo cardiovascular en la población general de Albacete , 1998 .

[39]  J. Hockley,et al.  Cardiovascular risk factors. , 1988, BMJ.

[40]  P. Armstrong,et al.  Randomised trials of secondary prevention programmes in coronary heart disease: systematic review , 2001, BMJ : British Medical Journal.